Sep 5, 2015 by Brian FeroldiWhy Walgreens Boots Alliance Inc. Fell 10% in AugustGlobal jitters caused this blue chip to have a rough month.
Sep 5, 2015 by Brian Feroldi, Tim Brugger, and Adam GalasThe 3 Smartest Moves to Make in a Stock Market CorrectionWhat should you do when the market falls? We asked our Motley Fool contributors to weigh in.
Sep 3, 2015 by Brian FeroldiAlexion Pharmaceuticals, Inc. Scores 2 Regulatory WinsThe company recently announced that European regulators gave two new drugs the green light. What does it mean for the company's bottom line?
Sep 3, 2015 by Brian FeroldiWhy Shares of Keryx Biopharmaceuticals Fell Hard TodayDownbeat analyst coverage mixed with a low price target sends the company's stock down hard.
Sep 3, 2015 by Brian FeroldiWhy Parkinson's Disease-Focused ACADIA Pharmaceuticals is Soaring TodayThe company officially submitted a New Drug Application to the FDA for its lead compound Nuplazid, and investors cheered the news.
Sep 2, 2015 by Brian FeroldiAmgen Inc.'s FDA Approval Holds Blockbuster PotentialAmgen's new LDL-lowering cholesterol medication Repatha gets the go-ahead from the FDA.
Sep 1, 2015 by Brian FeroldiBetter Buy: Fidelity Select Pharmaceuticals Portfolio or Fidelity Select Health Care Portfolio?Which one makes more sense for your porfolio?
Sep 1, 2015 by Brian FeroldiOpko Health Inc. and TESARO Inc Investors Have an Exciting Week AheadAn FDA decision date for these two companies is approaching fast -- investors be on your toes!
Aug 31, 2015 by Brian Feroldi5 Things MannKind Corporation's Management Team Wants You To KnowManagement had a lot of information to share with investors when it reported second quarter earnings. Here are 5 key takeaways.
Aug 31, 2015 by Brian FeroldiThis Top Diabetes Stock Just Extended Its LeadDiabetes all-star Dexcom managed to win an earlier-than-expected FDA approval for its new G5 Mobile system, and the company looks poised for more stellar growth.
Aug 30, 2015 by Brian Feroldi, Sean Williams, Eric Volkman, Jason Hall, and Jordan WathenThe 5 Best Business Executives Nobody's Heard OfThese five executives, who you probably have never heard of, have produced incredible results for shareholders and customers alike.
Aug 29, 2015 by Brian FeroldiShould Your Portfolio Say Hello to Halozyme Therapeutics Inc.?This small-cap biotech has been crushing the markets for years. Does it deserve a place in your portfolio?
Aug 28, 2015 by Brian FeroldiCan Novavax Inc.'s Stock Inoculate Your Portfolio From More Market Mayhem?This small-cap clinical-stage biopharma company is on a stellar run this year. Can it continue?
Aug 27, 2015 by Brian FeroldiCan Inovio Pharmaceuticals Finally Offer Investors a Bright Future?What does this long-time disappointment offer investors who want to get in today?
Aug 25, 2015 by Brian Feroldi3 Reasons Why Afrezza's Launch Has Been So DisappointingManagement blames its slow start for Afrezza, the company's inhaled insulin and only approved drug, on these three factors.
Aug 25, 2015 by Brian FeroldiCould Geron Corporation Be the Next Big Biotech Winner?Lets dig in to see if this small-cap stock could be the next home-run biotech investment.
Aug 24, 2015 by Brian FeroldiWhy Shares of HMS Holdings Corp Were Soaring Higher TodayShares of HMS are moving higher after the company received word that it won a new Medicaid contract with the state of New York.
Aug 21, 2015 by Brian Feroldi, Selena Maranjian, Brian Stoffel, Tim Brugger, and Todd CampbellThe 5 Best Stocks to Introduce a Kid to InvestingLooking to help get your children excited about investing? Our experts think these stocks will help you get started.
Aug 21, 2015 by Brian FeroldiWhy Shares of ImmunoGen Inc Were Up Big TodayShares of the cancer focused small-cap were up today on an otherwise down day for the markets.
Aug 21, 2015 by Brian FeroldiWhy Shares of Northwest Biotherapeutics Inc Are Crashing TodayNews of a phase 3 trial halt for the company's lead compound DCVax-L send investors running.
